[Update on melanoma: incidence, development and biological aspects]

¹Departamento de Dermatología, Clínica Universitaria de Navarra, Facultad de Medicina, Universidad de Navarra, Apdo 4209, 31080 Pamplona. predondo@unav.es

|July 30, 2003

Summary

Melanoma incidence has tripled due to factors like sun exposure. Understanding the immune system

Area of Science:

Context:

Melanoma, a highly metastatic skin cancer, has seen a threefold incidence increase in the past 40 years.
Key risk factors include genetic predisposition, intense sun exposure, and childhood sunburns, particularly in fair-skinned individuals.
A complex interplay exists between the host's immune system and skin cancer development and progression.

Purpose:

To explore the partially understood factors influencing melanoma progression from horizontal to invasive vertical growth.
To investigate the role of angiogenesis, mediated by factors like VEGF and bFGF, in tumor growth, invasion, and metastasis.
To examine the impact of T-helper cell (Th1/Th2) cytokine patterns and immunosuppressive cytokines (IL-10, TGF-beta) on melanoma prognosis.

Summary:

Angiogenesis, driven by pro-angiogenic cytokines (VEGF, bFGF), is crucial for melanoma's growth, invasion, and metastatic potential.
A Th1 cytokine profile in the tumor microenvironment is associated with disease regression, whereas a Th2 profile promotes invasion and metastasis.
Tumor cells may suppress host immunity through immunosuppressive cytokines (IL-10, TGF-beta, VEGF) and Fas-L expression, creating an immunologically privileged tumor environment.

Impact:

Elucidating the immune system's role in melanoma progression can lead to novel therapeutic strategies.
Understanding angiogenesis and cytokine signaling provides targets for anti-cancer drug development.
Identifying mechanisms of immune evasion by melanoma cells could inform immunotherapy approaches.

Related Experiment Videos